International Journal of Drug Policy
Volume 21, Issue 3 , Pages 229-233 , May 2010

Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine

  • Michael Schaub

      Affiliations

    • Research Institute for Public Health and Addiction, Konradstrasse 32, 8031 Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 448 11 65; fax: +41 44 448 11 71.
    • ,
  • Victor Chtenguelov

      Affiliations

    • Ukrainian Institute for Public Health Policy, Kiev, Ukraine
    • ,
  • Emilis Subata

      Affiliations

    • University Medical Faculty, Vilnius, Lithuania
    • ,
  • Gundo Weiler

      Affiliations

    • WHO Country Office in Ukraine, Kiev, Ukraine
    • ,
  • Ambros Uchtenhagen

      Affiliations

    • Research Institute for Public Health and Addiction, Konradstrasse 32, 8031 Zurich, Switzerland

Received 24 July 2009 ,Revised 5 October 2009 ,Accepted 16 October 2009.

References 

  1. Booth RE, Kennedy J, Brewster T, Semerik O. Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs. 2003;35:419–426
  2. Booth RE, Kwiatkowski CF, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Corsi KF, et al. Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug and Alcohol Dependence. 2006;82:49–55
  3. Bruce RD, Dvoryak S, Sylla L, Altice FL. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine programme description and policy implications. International Journal of Drug Policy. 2007;18:326–328
  4. Fry CL, Lintzeris N. Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction. 2003;98:171–178
  5. International HIV/AIDS Alliance. (2009). Annual report 2008. Retrieved 24th July 2009 from http://www.aidsalliance.org.ua/ru/library/our/finalreport/pdf/ar_2008_en.pdf.
  6. Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP. The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sexually Transmitted Infections. 2008;84:37–41
  7. Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction. 2008;103:1484–1492
  8. McLellan AT, Kushner H, Metzger D, Peters F. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  9. Raykhert I, Miskinis K, Lepshyna S, Kosinova O, Kovalyova A, Zaleskis R, et al. HIV seroprevalence among new TB patients in the civilian and prisoner populations of Donetsk Oblast, Ukraine. Scandinavian Journal of Infectious Diseases. 2008;40:655–662
  10. Sadikova NV, Shuliak IuA, Zveriaeva IK, Ershova ON, Kuzina LE, Kirillova IL, et al. Prevalence of HBV and HCV markers in patients of specialized medical institutions. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii. 2006;7:28–33
  11. Schaub M, Subata E, Chtenguelov V, Weiler G, Uchtenhagen A. Feasibility of buprenorphine maintenance therapy programs in the Ukraine: First promising treatment outcomes. European Addiction Research. 2009;15:157–162
  12. UNAIDS . AIDS epidemic update: December 2007. Geneva: WHO/UNAIDS; 2008;
  13. Vickerman P, Kumaranayake L, Balakireva O, Guinness L, Artyukh O, Semikop T, et al. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sexually Transmitted Diseases. 2006;33:89–102

PII: S0955-3959(09)00131-5

doi: 10.1016/j.drugpo.2009.10.005

International Journal of Drug Policy
Volume 21, Issue 3 , Pages 229-233 , May 2010

Article Tools